The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Liposomal irinotecan, carboplatin or oxaliplatin (LyRICX) with or without nivolumab in the first-line treatment of metastatic or irresectable esophagogastric adenocarcinoma: A randomized phase 2 study.
 
Denice Kamp
No Relationships to Disclose
 
Merel van Velzen
No Relationships to Disclose
 
Rob Kessels
Honoraria - Pierre Fabre (Inst)
 
Sebastiaan Siegerink
No Relationships to Disclose
 
Anne May
No Relationships to Disclose
 
Irene Hellemond
No Relationships to Disclose
 
Theo Van Voorthuizen
Travel, Accommodations, Expenses - Ipsen
 
Ronald Hoekstra
No Relationships to Disclose
 
Marco Polee
No Relationships to Disclose
 
Sarah Derks
Consulting or Advisory Role - BMS GmbH & Co. KG (Inst)
Speakers' Bureau - Benecke (Inst); BMS GmbH & Co. KG (Inst)
Research Funding - Incyte (Inst)
 
Nadia Haj Mohammad
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb/Pfizer (Inst); Merck/Pfizer (Inst); Servier (Inst)
Speakers' Bureau - Jaap (Inst); Medtalks (Inst)
Expert Testimony - Nutricia (Inst)
 
Hanneke Van Laarhoven
Consulting or Advisory Role - Amgen (Inst); Amphera (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Daiichi (Inst); MSD Oncology (Inst); MyeoloidTx (Inst)
Speakers' Bureau - AstraZeneca (Inst); BMS (Inst); CongressCare (Inst); Daiichy Sankyo (Inst); MedTalks (Inst); Travel Congress Management (Inst); Uitgeverij Jaap (Inst)
Research Funding - Amgen (Inst); Auristone; BMS (Inst); Incyte (Inst); Merck KGaA (Inst); ORCA Therapeutics (Inst); Servier (Inst)
Travel, Accommodations, Expenses - AstraZeneca